文献速递糖尿病肥胖与代谢综合征

脂代谢基因DNA甲基化驱动脂联素水平与代谢疾病

DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease.
PubMed 文献 · Diabetologia · 2025-10-08

该研究对五个欧洲队列进行全表观基因组荟萃分析,在超过40万个CpG位点中分析血清脂联素(n=2791)和瘦素(n=3661)与白细胞DNA甲基化的关联。研究发现脂联素关联73个CpG、瘦素关联211个CpG,整合分析及双向双样本孟德尔随机化识别出两个CpG位点可能驱动脂联素水平与代谢健康。

要点

  • 脂联素与73个CpG、瘦素与211个CpG稳健关联,多与代谢综合征风险因子相关。
  • 35个脂联素相关CpG链接46个基因表达,100个瘦素相关CpG链接151个基因表达。
  • 两个CpG(分别注释至ADIPOQ及SREBF1表达)被孟德尔随机化识别为脂联素与代谢健康的可能驱动因素。

核心结论

  • 大规模整合分析揭示了脂联素与瘦素同2型糖尿病及相关风险基因调控的功能特异性DNA甲基化差异之间的关联。

研究设计与样本

  • 对五个欧洲队列进行全表观基因组荟萃分析,分析血清脂联素(n=2791)和瘦素(n=3661)与白细胞DNA甲基化在超过400,000个CpG位点的关联。

主要发现

  • 脂联素与73个CpG位点稳健关联,瘦素与211个CpG位点稳健关联,许多位点同时与代谢综合征风险因子相关并位于增强子区。
  • 整合分析将35个脂联素相关CpG链接至46个基因表达,100个瘦素相关CpG链接至151个基因表达,涉及基因富集于脂质转运(如ABCG1)、代谢(如CPT1A)和生物合成(如DHCR24)。
  • 双向双样本孟德尔随机化识别两个CpG位点可能驱动脂联素水平与代谢健康:一个注释至ADIPOQ,另一个与SREBF1表达相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Despite playing critical roles in the pathophysiology of type 2 diabetes and other metabolic disorders, the molecular mechanisms underlying circulating adipokine levels remain poorly understood. By identifying genomic regions involved in the regulation of adipokine levels and adipokine-mediated disease risk, we can improve our understanding of type 2 diabetes pathogenesis and inter-individual differences in metabolic risk. METHODS: We conducted an epigenome-wide meta-analysis of associations between serum adiponectin (n=2791) and leptin (n=3661) and leukocyte DNA methylation at over 400,000 CpG sites across five European cohorts. The resulting methylation signatures were followed up using functional genomics, integrative analyses and causal inference methods. RESULTS: Our findings revealed robust associations with adiponectin at 73 CpGs and leptin at 211 CpGs. Many of the identified sites were also associated with risk factors for the metabolic syndrome and located in enhancers close to relevant transcription factor binding sites. Integrative analyses additionally linked 35 of the adiponectin-associated CpGs to the expression of 46 genes, and 100 of the leptin-associated CpGs to the expression of 151 genes, with implicated genes enriched for lipid transport (e.g. ABCG1), metabolism (e.g. CPT1A) and biosynthesis (e.g. DHCR24). Bidirectional two-sample Mendelian randomisation further identified two specific CpG sites as plausible drivers of both adiponectin levels and metabolic health: one annotated to ADIPOQ, the gene encoding adiponectin; and another linked to the expression of SREBF1, an established modifier of type 2 diabetes risk known to exert its effects via adiponectin. CONCLUSIONS/INTERPRETATION: Taken together, these large-scale and integrative analyses uncovered links between adipokines and widespread, yet functionally specific, differences in regulation of genes with a central role in type 2 diabetes and its risk factors.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Sinke L, Delerue T, Wilson R, et al. DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease. Diabetologia. 2025. PMID: 41057690. doi:10.1007/s00125-025-06549-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。